StockMacro
Menu

DiaMedica Therapeutics

$8.25 +31% in 6 monthsMarket cap $445.1M

DMAC on XNAS, Health Care, DiaMedica Therapeutics Inc., job postings

Measures activity, not value. Not investment advice.

Short interest at 9.3% of shares, 24.8 days to cover, while the stock is up 14% in a year.

  • BadFree cash flow of -$33.8M over 12 months, against $34.9M cash
  • GoodInstitutional holders rose to 96 from 89 last quarter

Written by AI from the data on this page, 22 Nov 2026. Not investment advice.

Profile and fundamentals

From its SEC filings, 12 months to 30 Sep 2026

DiaMedica Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is engaged in developing treatment for ischemic diseases with two main clinical programs focused on acute ischemic stroke (AIS) and preeclampsia (PE). Its main product candidate DM199 (rinvecalinase alfa) is a recombinant form of human tissue kallikrein-1, which is a synthetic version of the naturally occurring protease enzyme kallikrein-1 and a rhKLK1 undergoing clinical development studies in both AIS and PE. The other product candidate in the company's pipeline is DM300, its patented recombinant human ulinastatin, a broad-spectrum serine protease inhibitor, being developed as a potential therapy for severe acute pancreatitis.

Industry
Pharmaceutical preparations (Health Care)
Employees
35
Website
diamedica.com
Listed
Nasdaq, US
Last results
12 Nov 2026
Next results
expected around 29 Mar 2027 (an estimate: a year ago it reported on 30 Mar 2026)
Revenue and net income per quarter. Quarter to 30 Sep 2026: net loss $11.3M.
Quarter to 31 Dec 2021: revenue –, net income -$3.2MQuarter to 31 Mar 2022: revenue –, net income -$3.5MQuarter to 30 Jun 2022: revenue –, net income -$3.4MQuarter to 30 Sep 2022: revenue –, net income -$3.1MQuarter to 31 Dec 2022: revenue –, net income -$3.8MQuarter to 31 Mar 2023: revenue –, net income -$5.3MQuarter to 30 Jun 2023: revenue –, net income -$4.5MQuarter to 30 Sep 2023: revenue –, net income -$4.5MQuarter to 31 Dec 2023: revenue –, net income -$5.2MQuarter to 31 Mar 2024: revenue –, net income -$5.2MQuarter to 30 Jun 2024: revenue –, net income -$5.1MQuarter to 30 Sep 2024: revenue –, net income -$6.3MQuarter to 31 Dec 2024: revenue –, net income -$7.9MQuarter to 31 Mar 2025: revenue –, net income -$7.7MQuarter to 30 Jun 2025: revenue –, net income -$7.7MQuarter to 30 Sep 2025: revenue –, net income -$8.6MQuarter to 31 Dec 2025: revenue –, net income -$8.7MQuarter to 31 Mar 2026: revenue –, net income -$10.0MQuarter to 30 Jun 2026: revenue –, net income -$10.1MQuarter to 30 Sep 2026: revenue –, net income -$11.3M
31 Dec 2021RevenueNet incomeNet losstallest bar $11.3M30 Sep 2026
See the numbers
Quarter toRevenueNet income
30 Sep 2026–-$11.3M
30 Jun 2026–-$10.1M
31 Mar 2026–-$10.0M
31 Dec 2025–-$8.7M
30 Sep 2025–-$8.6M
30 Jun 2025–-$7.7M
31 Mar 2025–-$7.7M
31 Dec 2024–-$7.9M
30 Sep 2024–-$6.3M
30 Jun 2024–-$5.1M
31 Mar 2024–-$5.2M
31 Dec 2023–-$5.2M
30 Sep 2023–-$4.5M
30 Jun 2023–-$4.5M
31 Mar 2023–-$5.3M
31 Dec 2022–-$3.8M
30 Sep 2022–-$3.1M
30 Jun 2022–-$3.4M
31 Mar 2022–-$3.5M
31 Dec 2021–-$3.2M
Fundamentals, 12 months to 30 Sep 2026
MeasureLatestYear beforePeer median
RevenueSales over the last 12 months reported. – –
Revenue growthRevenue of the last 12 months compared with the 12 months before. – +11%
Net incomeProfit after all costs and taxes over the last 12 months reported. Negative is a loss. -$40.2M -$31.9M
EPS (diluted)Earnings per share: net income divided by the shares, counting options and convertibles. Left blank when the figures as filed do not fit today's share count (after a split). – –
Gross marginWhat is left of each dollar of sales after the direct cost of making the product or service. – – 73.2%
Operating marginOperating income as a share of sales: profit from the business before interest and taxes. – – -25.0%
Net marginNet income as a share of sales: what the owners keep of each dollar sold. – – -18.2%
Return on equityNet income of the last 12 months divided by shareholders' equity (the average of the latest balance sheet and the one a year earlier): the profit made on the owners' money. -100% -58.8%
Free cash flowCash from operations minus capital spending over the last 12 months: cash the business produced. -$33.8M -$27.8M
CashCash, cash equivalents and short-term investments on the latest balance sheet. $34.9M $55.3M
DebtShort- and long-term borrowings on the latest balance sheet. Operating leases are not counted. $0 $0
Net debtDebt minus cash. Negative means the company holds more cash than it owes (net cash). -$34.9M (net cash) -$55.3M
Debt to equityDebt divided by shareholders' equity on the latest balance sheet: how much is borrowed for each dollar the owners have in the company. Blank when equity is negative. 0.0 0.0
Book value per shareShareholders' equity (assets minus liabilities) on the latest balance sheet divided by the shares outstanding. $0.53
P/EPrice to earnings: market cap divided by net income of the last 12 months. What investors pay for one dollar of yearly profit. Blank when the company made a loss. loss 19.3
P/SPrice to sales: market cap divided by revenue of the last 12 months. – 5.0
EV/SalesEnterprise value (market cap plus debt minus cash) divided by revenue of the last 12 months. – 5.0
P/BPrice to book: market cap divided by shareholders' equity on the latest balance sheet. Blank when equity is negative. 15.5 2.0

Latest = 12 months to 30 Sep 2026; balance-sheet lines at its end. Peer median: companies in the same industry (SIC code), or the sector when the industry is small.

Peers nearest by market cap, its own industry first

CompanyMarket capP/EP/SRevenue growthNet margin
DiaMedica TherapeuticsDMAC (this company) $445.1Mloss–––
CytomX TherapeuticsCTMX $442.5Mloss31.5-88%-609%
Lyell ImmunopharmaLYEL $441.8Mlossover 999-63%–
Capricor TherapeuticsCAPR $441.3Mloss–––
Shattuck LabsSTTK $454.2Mloss–––
Assembly BiosciencesASMB $454.4Mloss6.8+80%-16.6%

Insider Buy/Sell Shares the company's insiders (directors, officers and owners of 10% or more) bought minus what they sold on the open market in the last 90 days, from their Form 4 filings.

–

No data for this company

Institutional holders The number of institutional investment managers (13F filers: funds, pensions, asset managers) reporting the stock, compared with the quarter before. 13F reports are public 45 days after quarter end and show long positions only.

+7.9%

96 13F filers vs 89

Institutional ownership Shares held by 13F filers at the latest quarter end, divided by the shares outstanding in the company's latest filing. Above 100% usually means a stale share count or double counting, and is marked.

24%

12.8M shares held by 13F filers (30 Sep 2026) of 54.0M outstanding (9 Nov 2026)

Short interest Shares sold short and not yet bought back, divided by the shares outstanding in the company's latest filing. From FINRA's latest short interest report: FINRA reports twice a month and publishes 7 business days after the settlement date. Above 100% means a stale share count, and is marked.

9.3%

5.0M shares sold short (30 Oct 2026) of 54.0M outstanding (9 Nov 2026)

Days to cover Short interest divided by the stock's average daily trading volume, as FINRA publishes it: how many days of normal trading it would take short sellers to buy back every share. Latest report.

24.8

5.0M shares sold short (30 Oct 2026) divided by the stock's average daily volume, as FINRA publishes it

Short interest change How the number of shares sold short changed between FINRA's two latest reports, about two weeks apart.

-4.2%

5.2M shares sold short in the report before, 5.0M on 30 Oct 2026

Short sale volume Share of the stock's latest daily volume on FINRA-reported off-exchange venues that was sold short. Market makers sell short routinely, so 40% to 50% is normal; compare it with the company's own 1-year average in the cell's details. A daily flow, not short interest.

33%

33% of off-exchange volume on 20 Nov 2026 was short sales; 1-year average 53%

Open jobs Job postings open on the company's own careers site today, where we track it. Blank when we do not track this company's careers site yet.

–

We do not track this company's careers site yet.

Open jobs change How the number of open job postings changed over the last 30 days: total hiring demand, any job, any country. Shown only once we have tracked the company for 30 days.

–

We do not track this company's careers site yet.

Employees Total staff the company reported in its latest annual report (10-K), with the change from the year before when both years are reported.

–

No headcount in its annual reports in our data.

Visa hiring (foreign workers) Applications to hire foreign specialists on H-1B and E-3 visas certified by the Labor Department in the last 12 months, compared with the 12 months before. This is NOT total hiring: most hires need no visa. Open jobs shows total hiring where we track it.

–

No data for this company

Revenue growth Sales in the latest reported quarter compared with the same quarter a year earlier.

–

No data for this company

Capital spending Money spent on buildings, machines and equipment in the latest quarter, compared with the same quarter a year earlier.

–

No data for this company

Federal contracts Money the US government committed to the company in contracts and grants over the last 12 months.

–

No data for this company

Lobbying What the company reported spending on federal lobbying over the last four quarters.

–

No data for this company

Layoff notices Workers named in state WARN layoff notices over the last 12 months (employers must file them 60 days before a large layoff).

–

No data for this company

News (7d) Articles about the company published in the last 7 days, from our Google News collection (one search per company, every half hour). Blank when we do not collect news for this company.

4

4 articles in the last 7 days; its usual week has 1 (the median of the 26 weeks before).

News vs usual Articles in the last 7 days divided by the company's usual week: the median week of the 26 weeks before. Blank when the usual week has fewer than one article.

4.0×

4 articles in the last 7 days; its usual week has 1.

Price $8.25 on 20 Nov 2026, +14% over 12 months (12-month range $5.33 to $10.77)

  • Sharp change
  • 8-K and other filings
Insider net buying (open market). Insiders bought a net $7.6M in the last 12 months (the 12 months before: $22.8M).
Capital spending per quarter. Capital spending $10K in the latest quarter, -38% on a year earlier.
Institutional holders (13F filers). 96 13F filers reported holding it in the latest 13F quarter, +25% on a year earlier.

Every point sits on the day the fact became public (filing acceptance or publication), not the day it happened; prices through 20 Nov 2026. Hover or tap a marker for the fact; click it for the evidence or the source. No data here for: h-1b/e-3 applications certified, revenue per quarter, federal obligations, lobbying spend, workers in warn layoff notices.

See the numbers
Dated facts on the price chart (newest 100)
Became publicKindFact
16 Dec 2025Sharp changeShort interest spike: short interest spike, 5.3M vs usual 978K (2025-11-28); 34.7x the same period a year earlier
2 Dec 2025Sharp changeShort interest spike: short interest spike, 5.0M vs usual 738K (2025-11-14); 29.0x the same period a year earlier
18 Nov 2025Sharp changeShort interest spike: short interest spike, 4.1M vs usual 496K (2025-10-31); 23.5x the same period a year earlier
28 Oct 2025Sharp changeShort interest spike: short interest spike, 4.1M vs usual 369K (2025-10-15); 22.5x the same period a year earlier
14 Oct 2025Sharp changeShort interest spike: short interest spike, 4.2M vs usual 315K (2025-09-30); 27.8x the same period a year earlier
30 Sep 2025Sharp changeShort interest spike: short interest spike, 4.1M vs usual 259K (2025-09-15); 29.7x the same period a year earlier
16 Sep 2025Sharp changeShort interest spike: short interest spike, 4.0M vs usual 243K (2025-08-29); 29.0x the same period a year earlier
2 Sep 2025Sharp changeShort interest spike: short interest spike, 3.8M vs usual 228K (2025-08-15); 27.0x the same period a year earlier
12 Aug 2025Sharp changeShort interest spike: short interest spike, 3.3M vs usual 216K (2025-07-31); 22.8x the same period a year earlier
6 Aug 20258-K and other filingsDirector or officer change
6 Aug 2025Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
29 Jul 2025Sharp changeShort interest spike: short interest spike, 2.4M vs usual 202K (2025-07-15); 13.9x the same period a year earlier
26 Jul 2025Sharp changeClustered insider buying: clustered insider buying (3 independent filers, 3 filing(s) in 30 days, value_usd total 16.8M)
24 Jul 20258-K and other filingsPrivate placement of securities (Form D)
1 Jul 2025Sharp changeShort interest spike: short interest spike, 1.2M vs usual 188K (2025-06-13); 9.6x the same period a year earlier
17 Jun 2025Sharp changeShort interest spike: short interest spike, 1.1M vs usual 179K (2025-05-30); 8.4x the same period a year earlier
3 Jun 2025Sharp changeShort interest spike: short interest spike, 857K vs usual 175K (2025-05-15); 6.7x the same period a year earlier
13 May 2025Sharp changeShort interest spike: short interest spike, 620K vs usual 175K (2025-04-30); 3.4x the same period a year earlier
6 Mar 20258-K and other filingsDirector or officer change
24 Feb 20258-K and other filingsDirector or officer change
24 Feb 2025Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
2 Jul 20248-K and other filingsPrivate placement of securities (Form D)
23 May 20248-K and other filingsDirector or officer change
10 Apr 20248-K and other filingsDirector or officer change
10 Apr 2024Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
5 Sep 20238-K and other filingsDirector or officer change
5 Sep 2023Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
1 Aug 2023Sharp changeShort interest spike: short interest spike, 796K vs usual 56K (2023-07-14); 16.5x the same period a year earlier
18 Jul 2023Sharp changeShort interest spike: short interest spike, 714K vs usual 54K (2023-06-30); 13.5x the same period a year earlier
27 Jun 20238-K and other filingsPrivate placement of securities (Form D)
27 Jun 2023Sharp changeClustered insider buying: clustered insider buying (6 independent filers, 6 filing(s) in 30 days, value_usd total 693K)
30 May 20238-K and other filingsDirector or officer change
18 Apr 20238-K and other filingsPrivate placement of securities (Form D)
6 Mar 20238-K and other filingsDirector or officer change
6 Mar 2023Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
6 Dec 2022Sharp changeClustered insider buying: clustered insider buying (3 independent filers, 4 filing(s) in 30 days, value_usd total 154K)
25 May 20228-K and other filingsDirector or officer change
19 May 20228-K and other filingsDirector or officer change
19 May 2022Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
Insider net buying (open market)
Month from 1 Jul 2022: $277K published
Month from 1 Nov 2022: $24K published
Month from 1 Dec 2022: $246K published
Month from 1 Apr 2023: $750K published
Month from 1 Jun 2023: $5.7M published
Month from 1 Nov 2023: $49K published
Month from 1 Jul 2024: $6.0M published
Month from 1 Jul 2025: $16.8M published
Month from 1 Sep 2025: $6.0M published
Month from 1 Dec 2025: $7.6M published
Capital spending per quarter
Quarter ended 31 Dec 2021: $7K, -84% on a year earlier; public on 15 Mar 2022
Quarter ended 31 Mar 2022: $0, -100% on a year earlier; public on 5 May 2022
Quarter ended 30 Jun 2022: $6K, +50% on a year earlier; public on 12 Aug 2022
Quarter ended 30 Sep 2022: $43K, +2050% on a year earlier; public on 10 Nov 2022
Quarter ended 31 Dec 2022: $32K, +357% on a year earlier; public on 29 Mar 2023
Quarter ended 31 Mar 2023: $7K; public on 16 May 2023
Quarter ended 30 Jun 2023: $4K, -33% on a year earlier; public on 15 Aug 2023
Quarter ended 30 Sep 2023: $10K, -77% on a year earlier; public on 14 Nov 2023
Quarter ended 31 Dec 2023: $3K, -91% on a year earlier; public on 20 Mar 2024
Quarter ended 31 Mar 2024: $9K, +29% on a year earlier; public on 9 May 2024
Quarter ended 30 Sep 2024: $9K, -10% on a year earlier; public on 14 Nov 2024
Quarter ended 31 Dec 2024: $7K, +133% on a year earlier; public on 18 Mar 2025
Quarter ended 31 Mar 2025: $12K, +33% on a year earlier; public on 14 May 2025
Quarter ended 30 Jun 2025: $6K; public on 13 Aug 2025
Quarter ended 30 Sep 2025: $16K, +78% on a year earlier; public on 13 Nov 2025
Quarter ended 31 Dec 2025: $6K, -14% on a year earlier; public on 31 Mar 2026
Quarter ended 31 Mar 2026: $8K, -33% on a year earlier; public on 7 May 2026
Quarter ended 30 Jun 2026: $3K, -50% on a year earlier; public on 11 Aug 2026
Quarter ended 30 Sep 2026: $10K, -38% on a year earlier; public on 13 Nov 2026
Institutional holders (13F filers)
31 Dec 2021 report: 37; public on 14 Feb 2022
31 Mar 2022 report: 31; public on 16 May 2022
30 Jun 2022 report: 25; public on 15 Aug 2022
30 Sep 2022 report: 20; public on 14 Nov 2022
31 Dec 2022 report: 24; public on 14 Feb 2023
31 Mar 2023 report: 22; public on 15 May 2023
30 Jun 2023 report: 28; public on 14 Aug 2023
30 Sep 2023 report: 33; public on 14 Nov 2023
31 Dec 2023 report: 36; public on 14 Feb 2024
31 Mar 2024 report: 31; public on 15 May 2024
30 Jun 2024 report: 28; public on 14 Aug 2024
30 Sep 2024 report: 40; public on 14 Nov 2024
31 Dec 2024 report: 45; public on 14 Feb 2025
31 Mar 2025 report: 57; public on 15 May 2025
30 Jun 2025 report: 55; public on 14 Aug 2025
30 Sep 2025 report: 77; public on 14 Nov 2025
31 Dec 2025 report: 90; public on 17 Feb 2026
31 Mar 2026 report: 94; public on 15 May 2026
30 Jun 2026 report: 89; public on 14 Aug 2026
30 Sep 2026 report: 96; public on 16 Nov 2026

What is unusual now

  • Nothing unusual in the last 90 days: no change appeared. Its most unusual measure now is insider open-market buying (USD, Form 4) at $7.6M (8 Dec 2025), 11× its normal reading; higher than 96% of its own history.
  • Insider net buying (open market): Insiders bought a net $7.6M in the last 12 months (the 12 months before: $22.8M).
  • Capital spending per quarter: Capital spending $10K in the latest quarter, -38% on a year earlier.
  • Institutional holders (13F filers): 96 13F filers reported holding it in the latest 13F quarter, +25% on a year earlier.

Latest records

The names and amounts behind the totals, newest first

Insider trades

All 49 insider trades

No trades in the last 90 days; the latest was filed 8 Dec 2025. Open-market trades by officers, directors and 10% owners.

FiledInsiderTradeSharesPriceValueSource
8 Dec 2025Ab Trill and 1 other10% ownerBuy1,061,277$7.19$7.6MForm 4
4 Sep 2025Jan Stahlberg and 1 other10% ownerBuy1,000,000$5.96$6.0MForm 4
25 Jul 2025Richard Jacinto II10% ownerBuy400,000$3.50$1.4MForm 4
25 Jul 2025Jan Stahlberg and 1 other10% ownerBuy1,542,857$3.50$5.4MForm 4
25 Jul 2025Thomas Von Koch and 2 others10% ownerBuy2,857,142$3.50$10.0MForm 4
1 Jul 2024Jan Stahlberg and 1 other10% ownerBuy1,200,000$2.50$3.0MForm 4
1 Jul 2024Private Ab TomEnterprise and 2 others10% ownerBuy1,200,000$2.50$3.0MForm 4
16 Nov 2023David J. WambekeChief Business OfficerBuy20,000$2.46$49KForm 4

96 institutions reported shares at the end of Q3 2026, 24% of the shares outstanding; 15 opened a position, 7 sold out. From 13F reports.

InstitutionShares% of companyValueChange vs Q2 2026
Cooperman Leon G3.5M6.39%$28.5MNo change
BlackRock, Inc.2.2M4.09%$18.3M-43K-1.9%
Geode Capital Management, LLC894K1.66%$7.4M-2880%
Millennium Management LLC831K1.54%$6.9M-14K-1.7%
State Street Corp660K1.22%$5.5M+13K+2.0%
Bleichroeder LP382K0.71%$3.2MNo change
Vanguard Capital Management LLC361K0.67%$3.0M+5,033+1.4%
Osaic Holdings, Inc.330K0.61%$2.7M-8,012-2.4%
Northern Trust Corp326K0.60%$2.7M-1,222-0.4%
Vanguard Portfolio Management LLC257K0.48%$2.1M+4,839+1.9%

Company events

All 37 company events

Nothing in 12 months; the latest was filed 12 Aug 2025. Results releases and routine reports are left out.

FiledWhat happenedSource
12 Aug 2025Signed a major agreement8-K
6 Aug 2025Director or officer change8-K
24 Jul 2025Private placement of securities (Form D)$30.1M sold of $30.1M offeredD
21 Jul 2025Signed a major agreementSame filing: sold shares privately8-K
6 Mar 2025Director or officer change8-K
24 Feb 2025Director or officer change8-K
2 Jul 2024Private placement of securities (Form D)$11.8M sold of $11.8M offeredD
26 Jun 2024Signed a major agreementSame filing: sold shares privately8-K

The 5 newest of 47 articles that name the company.

Timeline
Kind of data

Several things at once

Two or more unrelated kinds of records unusual within 30 days

26 Jul 2025confirmed

Confirmed across sources Insiders and Short interest and volume

DiaMedica Therapeutics (DMAC): had 3 insiders buy $16.8M of its shares on the open market within 30 days (3 filings), while it had 4.1M shares sold short in the 15 Oct 2025 report, 22× the same report last year. Two unrelated kinds of activity within 168 days.

  • Short interest and volume: Short interest spike, became public on 26 Jun 2025
  • Insiders: Clustered insider buying, became public on 26 Jul 2025
  • Short interest and volume: Short interest spike, became public on 25 Jul 2025
  • Short interest and volume: Short interest spike, became public on 12 Aug 2025
  • Short interest and volume: Short interest spike, became public on 27 Aug 2025
  • Short interest and volume: Short interest spike, became public on 11 Sep 2025
  • Short interest and volume: Short interest spike, became public on 25 Sep 2025
  • Short interest and volume: Short interest spike, became public on 10 Oct 2025
  • Short interest and volume: Short interest spike, became public on 25 Oct 2025
  • Short interest and volume: Short interest spike, became public on 13 Nov 2025
  • Short interest and volume: Short interest spike, became public on 26 Nov 2025
  • Short interest and volume: Short interest spike, became public on 10 Dec 2025
2024-10-15: 183K2024-10-31: 176K2024-11-15: 172K2024-11-29: 151K2024-12-13: 195K2024-12-31: 223K2025-01-15: 209K2025-01-31: 192K2025-02-14: 232K2025-02-28: 254K2025-03-14: 264K2025-03-31: 366K2025-04-15: 371K2025-04-30: 620K2025-05-15: 857K2025-05-30: 1.1M2025-06-13: 1.2M2025-06-30: 2.1M2025-07-15: 2.4M2025-07-31: 3.3M2025-08-15: 3.8M2025-08-29: 4.0M2025-09-15: 4.1M2025-09-30: 4.2M2025-10-15: 4.1M
The 15 Oct 2025 report against the 24 reports before it. this reportearliernormal: 369K
See the evidence (12 changes)

Short interest and volume: Short interest spike became public on 26 Jun 2025

DiaMedica Therapeutics had 1.2M shares sold short in the 13 Jun 2025 report, 9.6× the same report last year.

This period
1.2M (the 13 Jun 2025 report)
Normal report (median of 24 earlier)
188K
Typical spread (median absolute deviation)
44K
How far from its usual level
+16.0
Same report last year
128K
History used
2,373 days
2024-06-14: 128K2024-06-28: 157K2024-07-15: 174K2024-07-31: 144K2024-08-15: 142K2024-08-30: 139K2024-09-13: 138K2024-09-30: 152K2024-10-15: 183K2024-10-31: 176K2024-11-15: 172K2024-11-29: 151K2024-12-13: 195K2024-12-31: 223K2025-01-15: 209K2025-01-31: 192K2025-02-14: 232K2025-02-28: 254K2025-03-14: 264K2025-03-31: 366K2025-04-15: 371K2025-04-30: 620K2025-05-15: 857K2025-05-30: 1.1M2025-06-13: 1.2M
the 13 Jun 2025 report24 earlier reportsnormal: 188K

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Insiders: Clustered insider buying became public on 26 Jul 2025

DiaMedica Therapeutics had 3 insiders buy $16.8M of its shares on the open market within 30 days (3 filings).

Independent buyers
3
Purchase filings (Form 4, code P)
3
Total bought
$16.8M
Window
26 Jun 2025 to 26 Jul 2025

Fires when at least 3 independent insiders (joint filers count once) buy on the open market in 30 days, in at least 2 filings, for $100K or more in total; amendments do not count.

Short interest and volume: Short interest spike became public on 25 Jul 2025

DiaMedica Therapeutics had 2.4M shares sold short in the 15 Jul 2025 report, 14× the same report last year.

This period
2.4M (the 15 Jul 2025 report)
Normal report (median of 24 earlier)
202K
Typical spread (median absolute deviation)
55K
How far from its usual level
+27.3
Same report last year
174K
History used
2,405 days
2024-07-15: 174K2024-07-31: 144K2024-08-15: 142K2024-08-30: 139K2024-09-13: 138K2024-09-30: 152K2024-10-15: 183K2024-10-31: 176K2024-11-15: 172K2024-11-29: 151K2024-12-13: 195K2024-12-31: 223K2025-01-15: 209K2025-01-31: 192K2025-02-14: 232K2025-02-28: 254K2025-03-14: 264K2025-03-31: 366K2025-04-15: 371K2025-04-30: 620K2025-05-15: 857K2025-05-30: 1.1M2025-06-13: 1.2M2025-06-30: 2.1M2025-07-15: 2.4M
the 15 Jul 2025 report24 earlier reportsnormal: 202K

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Short interest and volume: Short interest spike became public on 12 Aug 2025

DiaMedica Therapeutics had 3.3M shares sold short in the 31 Jul 2025 report, 23× the same report last year.

This period
3.3M (the 31 Jul 2025 report)
Normal report (median of 24 earlier)
216K
Typical spread (median absolute deviation)
68K
How far from its usual level
+30.3
Same report last year
144K
History used
2,421 days
2024-07-31: 144K2024-08-15: 142K2024-08-30: 139K2024-09-13: 138K2024-09-30: 152K2024-10-15: 183K2024-10-31: 176K2024-11-15: 172K2024-11-29: 151K2024-12-13: 195K2024-12-31: 223K2025-01-15: 209K2025-01-31: 192K2025-02-14: 232K2025-02-28: 254K2025-03-14: 264K2025-03-31: 366K2025-04-15: 371K2025-04-30: 620K2025-05-15: 857K2025-05-30: 1.1M2025-06-13: 1.2M2025-06-30: 2.1M2025-07-15: 2.4M2025-07-31: 3.3M
the 31 Jul 2025 report24 earlier reportsnormal: 216K

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Short interest and volume: Short interest spike became public on 27 Aug 2025

DiaMedica Therapeutics had 3.8M shares sold short in the 15 Aug 2025 report, 27× the same report last year.

This period
3.8M (the 15 Aug 2025 report)
Normal report (median of 24 earlier)
228K
Typical spread (median absolute deviation)
81K
How far from its usual level
+30.1
Same report last year
142K
History used
2,436 days
2024-08-15: 142K2024-08-30: 139K2024-09-13: 138K2024-09-30: 152K2024-10-15: 183K2024-10-31: 176K2024-11-15: 172K2024-11-29: 151K2024-12-13: 195K2024-12-31: 223K2025-01-15: 209K2025-01-31: 192K2025-02-14: 232K2025-02-28: 254K2025-03-14: 264K2025-03-31: 366K2025-04-15: 371K2025-04-30: 620K2025-05-15: 857K2025-05-30: 1.1M2025-06-13: 1.2M2025-06-30: 2.1M2025-07-15: 2.4M2025-07-31: 3.3M2025-08-15: 3.8M
the 15 Aug 2025 report24 earlier reportsnormal: 228K

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Short interest and volume: Short interest spike became public on 11 Sep 2025

DiaMedica Therapeutics had 4.0M shares sold short in the 29 Aug 2025 report, 29× the same report last year.

This period
4.0M (the 29 Aug 2025 report)
Normal report (median of 24 earlier)
243K
Typical spread (median absolute deviation)
98K
How far from its usual level
+26.2
Same report last year
139K
History used
2,450 days
2024-08-30: 139K2024-09-13: 138K2024-09-30: 152K2024-10-15: 183K2024-10-31: 176K2024-11-15: 172K2024-11-29: 151K2024-12-13: 195K2024-12-31: 223K2025-01-15: 209K2025-01-31: 192K2025-02-14: 232K2025-02-28: 254K2025-03-14: 264K2025-03-31: 366K2025-04-15: 371K2025-04-30: 620K2025-05-15: 857K2025-05-30: 1.1M2025-06-13: 1.2M2025-06-30: 2.1M2025-07-15: 2.4M2025-07-31: 3.3M2025-08-15: 3.8M2025-08-29: 4.0M
the 29 Aug 2025 report24 earlier reportsnormal: 243K

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Short interest and volume: Short interest spike became public on 25 Sep 2025

DiaMedica Therapeutics had 4.1M shares sold short in the 15 Sep 2025 report, 30× the same report last year.

This period
4.1M (the 15 Sep 2025 report)
Normal report (median of 24 earlier)
259K
Typical spread (median absolute deviation)
107K
How far from its usual level
+24.2
Same report last year
138K
History used
2,467 days
2024-09-13: 138K2024-09-30: 152K2024-10-15: 183K2024-10-31: 176K2024-11-15: 172K2024-11-29: 151K2024-12-13: 195K2024-12-31: 223K2025-01-15: 209K2025-01-31: 192K2025-02-14: 232K2025-02-28: 254K2025-03-14: 264K2025-03-31: 366K2025-04-15: 371K2025-04-30: 620K2025-05-15: 857K2025-05-30: 1.1M2025-06-13: 1.2M2025-06-30: 2.1M2025-07-15: 2.4M2025-07-31: 3.3M2025-08-15: 3.8M2025-08-29: 4.0M2025-09-15: 4.1M
the 15 Sep 2025 report24 earlier reportsnormal: 259K

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Short interest and volume: Short interest spike became public on 10 Oct 2025

DiaMedica Therapeutics had 4.2M shares sold short in the 30 Sep 2025 report, 28× the same report last year.

This period
4.2M (the 30 Sep 2025 report)
Normal report (median of 24 earlier)
315K
Typical spread (median absolute deviation)
153K
How far from its usual level
+17.3
Same report last year
152K
History used
2,482 days
2024-09-30: 152K2024-10-15: 183K2024-10-31: 176K2024-11-15: 172K2024-11-29: 151K2024-12-13: 195K2024-12-31: 223K2025-01-15: 209K2025-01-31: 192K2025-02-14: 232K2025-02-28: 254K2025-03-14: 264K2025-03-31: 366K2025-04-15: 371K2025-04-30: 620K2025-05-15: 857K2025-05-30: 1.1M2025-06-13: 1.2M2025-06-30: 2.1M2025-07-15: 2.4M2025-07-31: 3.3M2025-08-15: 3.8M2025-08-29: 4.0M2025-09-15: 4.1M2025-09-30: 4.2M
the 30 Sep 2025 report24 earlier reportsnormal: 315K

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Short interest and volume: Short interest spike became public on 25 Oct 2025

DiaMedica Therapeutics had 4.1M shares sold short in the 15 Oct 2025 report, 22× the same report last year.

This period
4.1M (the 15 Oct 2025 report)
Normal report (median of 24 earlier)
369K
Typical spread (median absolute deviation)
207K
How far from its usual level
+12.2
Same report last year
183K
History used
2,497 days
2024-10-15: 183K2024-10-31: 176K2024-11-15: 172K2024-11-29: 151K2024-12-13: 195K2024-12-31: 223K2025-01-15: 209K2025-01-31: 192K2025-02-14: 232K2025-02-28: 254K2025-03-14: 264K2025-03-31: 366K2025-04-15: 371K2025-04-30: 620K2025-05-15: 857K2025-05-30: 1.1M2025-06-13: 1.2M2025-06-30: 2.1M2025-07-15: 2.4M2025-07-31: 3.3M2025-08-15: 3.8M2025-08-29: 4.0M2025-09-15: 4.1M2025-09-30: 4.2M2025-10-15: 4.1M
the 15 Oct 2025 report24 earlier reportsnormal: 369K

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Short interest and volume: Short interest spike became public on 13 Nov 2025

DiaMedica Therapeutics had 4.1M shares sold short in the 31 Oct 2025 report, 23× the same report last year.

This period
4.1M (the 31 Oct 2025 report)
Normal report (median of 24 earlier)
496K
Typical spread (median absolute deviation)
334K
How far from its usual level
+7.3
Same report last year
176K
History used
2,513 days
2024-10-31: 176K2024-11-15: 172K2024-11-29: 151K2024-12-13: 195K2024-12-31: 223K2025-01-15: 209K2025-01-31: 192K2025-02-14: 232K2025-02-28: 254K2025-03-14: 264K2025-03-31: 366K2025-04-15: 371K2025-04-30: 620K2025-05-15: 857K2025-05-30: 1.1M2025-06-13: 1.2M2025-06-30: 2.1M2025-07-15: 2.4M2025-07-31: 3.3M2025-08-15: 3.8M2025-08-29: 4.0M2025-09-15: 4.1M2025-09-30: 4.2M2025-10-15: 4.1M2025-10-31: 4.1M
the 31 Oct 2025 report24 earlier reportsnormal: 496K

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Short interest and volume: Short interest spike became public on 26 Nov 2025

DiaMedica Therapeutics had 5.0M shares sold short in the 14 Nov 2025 report, 29× the same report last year.

This period
5.0M (the 14 Nov 2025 report)
Normal report (median of 24 earlier)
738K
Typical spread (median absolute deviation)
545K
How far from its usual level
+5.3
Same report last year
172K
History used
2,527 days
2024-11-15: 172K2024-11-29: 151K2024-12-13: 195K2024-12-31: 223K2025-01-15: 209K2025-01-31: 192K2025-02-14: 232K2025-02-28: 254K2025-03-14: 264K2025-03-31: 366K2025-04-15: 371K2025-04-30: 620K2025-05-15: 857K2025-05-30: 1.1M2025-06-13: 1.2M2025-06-30: 2.1M2025-07-15: 2.4M2025-07-31: 3.3M2025-08-15: 3.8M2025-08-29: 4.0M2025-09-15: 4.1M2025-09-30: 4.2M2025-10-15: 4.1M2025-10-31: 4.1M2025-11-14: 5.0M
the 14 Nov 2025 report24 earlier reportsnormal: 738K

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Short interest and volume: Short interest spike became public on 10 Dec 2025

DiaMedica Therapeutics had 5.3M shares sold short in the 28 Nov 2025 report, 35× the same report last year.

This period
5.3M (the 28 Nov 2025 report)
Normal report (median of 24 earlier)
978K
Typical spread (median absolute deviation)
785K
How far from its usual level
+3.7
Same report last year
151K
History used
2,541 days
2024-11-29: 151K2024-12-13: 195K2024-12-31: 223K2025-01-15: 209K2025-01-31: 192K2025-02-14: 232K2025-02-28: 254K2025-03-14: 264K2025-03-31: 366K2025-04-15: 371K2025-04-30: 620K2025-05-15: 857K2025-05-30: 1.1M2025-06-13: 1.2M2025-06-30: 2.1M2025-07-15: 2.4M2025-07-31: 3.3M2025-08-15: 3.8M2025-08-29: 4.0M2025-09-15: 4.1M2025-09-30: 4.2M2025-10-15: 4.1M2025-10-31: 4.1M2025-11-14: 5.0M2025-11-28: 5.3M
the 28 Nov 2025 report24 earlier reportsnormal: 978K

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Several things at once means two or more unrelated kinds of records changed sharply within 30 days. Records that come from the same documents (for example filings and the financials taken from them) count as one kind.

18 Jul 2023confirmed

Confirmed across sources Insiders and Short interest and volume

DiaMedica Therapeutics (DMAC): had 6 insiders buy $693K of its shares on the open market within 30 days (6 filings), while it had 796K shares sold short in the 14 Jul 2023 report, 16× the same report last year. Two unrelated kinds of activity within 35 days.

  • Insiders: Clustered insider buying, became public on 27 Jun 2023
  • Short interest and volume: Short interest spike, became public on 13 Jul 2023
  • Short interest and volume: Short interest spike, became public on 26 Jul 2023
2022-07-15: 48K2022-07-29: 54K2022-08-15: 53K2022-08-31: 30K2022-09-15: 77K2022-09-30: 29K2022-10-14: 101K2022-10-31: 53K2022-11-15: 35K2022-11-30: 43K2022-12-15: 40K2022-12-30: 85K2023-01-13: 80K2023-01-31: 34K2023-02-15: 41K2023-02-28: 41K2023-03-15: 59K2023-03-31: 91K2023-04-14: 97K2023-04-28: 92K2023-05-15: 84K2023-05-31: 66K2023-06-15: 71K2023-06-30: 714K2023-07-14: 796K
The 14 Jul 2023 report against the 24 reports before it. this reportearliernormal: 56K
See the evidence (3 changes)

Insiders: Clustered insider buying became public on 27 Jun 2023

DiaMedica Therapeutics had 6 insiders buy $693K of its shares on the open market within 30 days (6 filings).

Independent buyers
6
Purchase filings (Form 4, code P)
6
Total bought
$693K
Window
28 May 2023 to 27 Jun 2023

Fires when at least 3 independent insiders (joint filers count once) buy on the open market in 30 days, in at least 2 filings, for $100K or more in total; amendments do not count.

Short interest and volume: Short interest spike became public on 13 Jul 2023

DiaMedica Therapeutics had 714K shares sold short in the 30 Jun 2023 report, 14× the same report last year.

This period
714K (the 30 Jun 2023 report)
Normal report (median of 24 earlier)
54K
Typical spread (median absolute deviation)
18K
How far from its usual level
+13.2
Same report last year
53K
History used
1,659 days
2022-06-30: 53K2022-07-15: 48K2022-07-29: 54K2022-08-15: 53K2022-08-31: 30K2022-09-15: 77K2022-09-30: 29K2022-10-14: 101K2022-10-31: 53K2022-11-15: 35K2022-11-30: 43K2022-12-15: 40K2022-12-30: 85K2023-01-13: 80K2023-01-31: 34K2023-02-15: 41K2023-02-28: 41K2023-03-15: 59K2023-03-31: 91K2023-04-14: 97K2023-04-28: 92K2023-05-15: 84K2023-05-31: 66K2023-06-15: 71K2023-06-30: 714K
the 30 Jun 2023 report24 earlier reportsnormal: 54K

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Short interest and volume: Short interest spike became public on 26 Jul 2023

DiaMedica Therapeutics had 796K shares sold short in the 14 Jul 2023 report, 16× the same report last year.

This period
796K (the 14 Jul 2023 report)
Normal report (median of 24 earlier)
56K
Typical spread (median absolute deviation)
21K
How far from its usual level
+14.8
Same report last year
48K
History used
1,673 days
2022-07-15: 48K2022-07-29: 54K2022-08-15: 53K2022-08-31: 30K2022-09-15: 77K2022-09-30: 29K2022-10-14: 101K2022-10-31: 53K2022-11-15: 35K2022-11-30: 43K2022-12-15: 40K2022-12-30: 85K2023-01-13: 80K2023-01-31: 34K2023-02-15: 41K2023-02-28: 41K2023-03-15: 59K2023-03-31: 91K2023-04-14: 97K2023-04-28: 92K2023-05-15: 84K2023-05-31: 66K2023-06-15: 71K2023-06-30: 714K2023-07-14: 796K
the 14 Jul 2023 report24 earlier reportsnormal: 56K

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Several things at once means two or more unrelated kinds of records changed sharply within 30 days. Records that come from the same documents (for example filings and the financials taken from them) count as one kind.

Timeline

Changes and notable records, by the date each became public

  1. 10 Dec 2025Short interest and volume change

    had 5.3M shares sold short in the 28 Nov 2025 report, 35× the same report last year.

    Same report last year: 151K; its normal report is 978K.

    See the evidence
    This period
    5.3M (the 28 Nov 2025 report)
    Normal report (median of 24 earlier)
    978K
    Typical spread (median absolute deviation)
    785K
    How far from its usual level
    +3.7
    Same report last year
    151K
    History used
    2,541 days
    2024-11-29: 151K2024-12-13: 195K2024-12-31: 223K2025-01-15: 209K2025-01-31: 192K2025-02-14: 232K2025-02-28: 254K2025-03-14: 264K2025-03-31: 366K2025-04-15: 371K2025-04-30: 620K2025-05-15: 857K2025-05-30: 1.1M2025-06-13: 1.2M2025-06-30: 2.1M2025-07-15: 2.4M2025-07-31: 3.3M2025-08-15: 3.8M2025-08-29: 4.0M2025-09-15: 4.1M2025-09-30: 4.2M2025-10-15: 4.1M2025-10-31: 4.1M2025-11-14: 5.0M2025-11-28: 5.3M
    the 28 Nov 2025 report24 earlier reportsnormal: 978K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  2. 9 Dec 2025Insiders record

    TRILL AB (ten percent owner) and 1 other(s) bought 1,061,277 shares of DMAC ($7.6M) (dated 8 Dec 2025)

  3. 26 Nov 2025Short interest and volume change

    had 5.0M shares sold short in the 14 Nov 2025 report, 29× the same report last year.

    Same report last year: 172K; its normal report is 738K.

    See the evidence
    This period
    5.0M (the 14 Nov 2025 report)
    Normal report (median of 24 earlier)
    738K
    Typical spread (median absolute deviation)
    545K
    How far from its usual level
    +5.3
    Same report last year
    172K
    History used
    2,527 days
    2024-11-15: 172K2024-11-29: 151K2024-12-13: 195K2024-12-31: 223K2025-01-15: 209K2025-01-31: 192K2025-02-14: 232K2025-02-28: 254K2025-03-14: 264K2025-03-31: 366K2025-04-15: 371K2025-04-30: 620K2025-05-15: 857K2025-05-30: 1.1M2025-06-13: 1.2M2025-06-30: 2.1M2025-07-15: 2.4M2025-07-31: 3.3M2025-08-15: 3.8M2025-08-29: 4.0M2025-09-15: 4.1M2025-09-30: 4.2M2025-10-15: 4.1M2025-10-31: 4.1M2025-11-14: 5.0M
    the 14 Nov 2025 report24 earlier reportsnormal: 738K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  4. 13 Nov 2025Short interest and volume change

    had 4.1M shares sold short in the 31 Oct 2025 report, 23× the same report last year.

    Same report last year: 176K; its normal report is 496K.

    See the evidence
    This period
    4.1M (the 31 Oct 2025 report)
    Normal report (median of 24 earlier)
    496K
    Typical spread (median absolute deviation)
    334K
    How far from its usual level
    +7.3
    Same report last year
    176K
    History used
    2,513 days
    2024-10-31: 176K2024-11-15: 172K2024-11-29: 151K2024-12-13: 195K2024-12-31: 223K2025-01-15: 209K2025-01-31: 192K2025-02-14: 232K2025-02-28: 254K2025-03-14: 264K2025-03-31: 366K2025-04-15: 371K2025-04-30: 620K2025-05-15: 857K2025-05-30: 1.1M2025-06-13: 1.2M2025-06-30: 2.1M2025-07-15: 2.4M2025-07-31: 3.3M2025-08-15: 3.8M2025-08-29: 4.0M2025-09-15: 4.1M2025-09-30: 4.2M2025-10-15: 4.1M2025-10-31: 4.1M
    the 31 Oct 2025 report24 earlier reportsnormal: 496K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  5. 25 Oct 2025Short interest and volume change

    had 4.1M shares sold short in the 15 Oct 2025 report, 22× the same report last year.

    Same report last year: 183K; its normal report is 369K.

    See the evidence
    This period
    4.1M (the 15 Oct 2025 report)
    Normal report (median of 24 earlier)
    369K
    Typical spread (median absolute deviation)
    207K
    How far from its usual level
    +12.2
    Same report last year
    183K
    History used
    2,497 days
    2024-10-15: 183K2024-10-31: 176K2024-11-15: 172K2024-11-29: 151K2024-12-13: 195K2024-12-31: 223K2025-01-15: 209K2025-01-31: 192K2025-02-14: 232K2025-02-28: 254K2025-03-14: 264K2025-03-31: 366K2025-04-15: 371K2025-04-30: 620K2025-05-15: 857K2025-05-30: 1.1M2025-06-13: 1.2M2025-06-30: 2.1M2025-07-15: 2.4M2025-07-31: 3.3M2025-08-15: 3.8M2025-08-29: 4.0M2025-09-15: 4.1M2025-09-30: 4.2M2025-10-15: 4.1M
    the 15 Oct 2025 report24 earlier reportsnormal: 369K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  6. 10 Oct 2025Short interest and volume change

    had 4.2M shares sold short in the 30 Sep 2025 report, 28× the same report last year.

    Same report last year: 152K; its normal report is 315K.

    See the evidence
    This period
    4.2M (the 30 Sep 2025 report)
    Normal report (median of 24 earlier)
    315K
    Typical spread (median absolute deviation)
    153K
    How far from its usual level
    +17.3
    Same report last year
    152K
    History used
    2,482 days
    2024-09-30: 152K2024-10-15: 183K2024-10-31: 176K2024-11-15: 172K2024-11-29: 151K2024-12-13: 195K2024-12-31: 223K2025-01-15: 209K2025-01-31: 192K2025-02-14: 232K2025-02-28: 254K2025-03-14: 264K2025-03-31: 366K2025-04-15: 371K2025-04-30: 620K2025-05-15: 857K2025-05-30: 1.1M2025-06-13: 1.2M2025-06-30: 2.1M2025-07-15: 2.4M2025-07-31: 3.3M2025-08-15: 3.8M2025-08-29: 4.0M2025-09-15: 4.1M2025-09-30: 4.2M
    the 30 Sep 2025 report24 earlier reportsnormal: 315K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  7. 25 Sep 2025Short interest and volume change

    had 4.1M shares sold short in the 15 Sep 2025 report, 30× the same report last year.

    Same report last year: 138K; its normal report is 259K.

    See the evidence
    This period
    4.1M (the 15 Sep 2025 report)
    Normal report (median of 24 earlier)
    259K
    Typical spread (median absolute deviation)
    107K
    How far from its usual level
    +24.2
    Same report last year
    138K
    History used
    2,467 days
    2024-09-13: 138K2024-09-30: 152K2024-10-15: 183K2024-10-31: 176K2024-11-15: 172K2024-11-29: 151K2024-12-13: 195K2024-12-31: 223K2025-01-15: 209K2025-01-31: 192K2025-02-14: 232K2025-02-28: 254K2025-03-14: 264K2025-03-31: 366K2025-04-15: 371K2025-04-30: 620K2025-05-15: 857K2025-05-30: 1.1M2025-06-13: 1.2M2025-06-30: 2.1M2025-07-15: 2.4M2025-07-31: 3.3M2025-08-15: 3.8M2025-08-29: 4.0M2025-09-15: 4.1M
    the 15 Sep 2025 report24 earlier reportsnormal: 259K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  8. 11 Sep 2025Short interest and volume change

    had 4.0M shares sold short in the 29 Aug 2025 report, 29× the same report last year.

    Same report last year: 139K; its normal report is 243K.

    See the evidence
    This period
    4.0M (the 29 Aug 2025 report)
    Normal report (median of 24 earlier)
    243K
    Typical spread (median absolute deviation)
    98K
    How far from its usual level
    +26.2
    Same report last year
    139K
    History used
    2,450 days
    2024-08-30: 139K2024-09-13: 138K2024-09-30: 152K2024-10-15: 183K2024-10-31: 176K2024-11-15: 172K2024-11-29: 151K2024-12-13: 195K2024-12-31: 223K2025-01-15: 209K2025-01-31: 192K2025-02-14: 232K2025-02-28: 254K2025-03-14: 264K2025-03-31: 366K2025-04-15: 371K2025-04-30: 620K2025-05-15: 857K2025-05-30: 1.1M2025-06-13: 1.2M2025-06-30: 2.1M2025-07-15: 2.4M2025-07-31: 3.3M2025-08-15: 3.8M2025-08-29: 4.0M
    the 29 Aug 2025 report24 earlier reportsnormal: 243K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  9. 5 Sep 2025Insiders record

    STAHLBERG JAN (ten percent owner) and 1 other(s) bought 1,000,000 shares of DMAC ($6.0M) (dated 4 Sep 2025)

  10. 27 Aug 2025Short interest and volume change

    had 3.8M shares sold short in the 15 Aug 2025 report, 27× the same report last year.

    Same report last year: 142K; its normal report is 228K.

    See the evidence
    This period
    3.8M (the 15 Aug 2025 report)
    Normal report (median of 24 earlier)
    228K
    Typical spread (median absolute deviation)
    81K
    How far from its usual level
    +30.1
    Same report last year
    142K
    History used
    2,436 days
    2024-08-15: 142K2024-08-30: 139K2024-09-13: 138K2024-09-30: 152K2024-10-15: 183K2024-10-31: 176K2024-11-15: 172K2024-11-29: 151K2024-12-13: 195K2024-12-31: 223K2025-01-15: 209K2025-01-31: 192K2025-02-14: 232K2025-02-28: 254K2025-03-14: 264K2025-03-31: 366K2025-04-15: 371K2025-04-30: 620K2025-05-15: 857K2025-05-30: 1.1M2025-06-13: 1.2M2025-06-30: 2.1M2025-07-15: 2.4M2025-07-31: 3.3M2025-08-15: 3.8M
    the 15 Aug 2025 report24 earlier reportsnormal: 228K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  11. 12 Aug 2025Short interest and volume change

    had 3.3M shares sold short in the 31 Jul 2025 report, 23× the same report last year.

    Same report last year: 144K; its normal report is 216K.

    See the evidence
    This period
    3.3M (the 31 Jul 2025 report)
    Normal report (median of 24 earlier)
    216K
    Typical spread (median absolute deviation)
    68K
    How far from its usual level
    +30.3
    Same report last year
    144K
    History used
    2,421 days
    2024-07-31: 144K2024-08-15: 142K2024-08-30: 139K2024-09-13: 138K2024-09-30: 152K2024-10-15: 183K2024-10-31: 176K2024-11-15: 172K2024-11-29: 151K2024-12-13: 195K2024-12-31: 223K2025-01-15: 209K2025-01-31: 192K2025-02-14: 232K2025-02-28: 254K2025-03-14: 264K2025-03-31: 366K2025-04-15: 371K2025-04-30: 620K2025-05-15: 857K2025-05-30: 1.1M2025-06-13: 1.2M2025-06-30: 2.1M2025-07-15: 2.4M2025-07-31: 3.3M
    the 31 Jul 2025 report24 earlier reportsnormal: 216K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  12. 6 Aug 2025Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  13. 6 Aug 2025Filings record

    Director or officer change

  14. 26 Jul 2025several at once

    had 3 insiders buy $16.8M of its shares on the open market within 30 days (3 filings), while it had 4.1M shares sold short in the 15 Oct 2025 report, 22× the same report last year. Two unrelated kinds of activity within 168 days.

    See the evidence (12 changes)

    Short interest and volume: Short interest spike became public on 26 Jun 2025

    DiaMedica Therapeutics had 1.2M shares sold short in the 13 Jun 2025 report, 9.6× the same report last year.

    This period
    1.2M (the 13 Jun 2025 report)
    Normal report (median of 24 earlier)
    188K
    Typical spread (median absolute deviation)
    44K
    How far from its usual level
    +16.0
    Same report last year
    128K
    History used
    2,373 days
    2024-06-14: 128K2024-06-28: 157K2024-07-15: 174K2024-07-31: 144K2024-08-15: 142K2024-08-30: 139K2024-09-13: 138K2024-09-30: 152K2024-10-15: 183K2024-10-31: 176K2024-11-15: 172K2024-11-29: 151K2024-12-13: 195K2024-12-31: 223K2025-01-15: 209K2025-01-31: 192K2025-02-14: 232K2025-02-28: 254K2025-03-14: 264K2025-03-31: 366K2025-04-15: 371K2025-04-30: 620K2025-05-15: 857K2025-05-30: 1.1M2025-06-13: 1.2M
    the 13 Jun 2025 report24 earlier reportsnormal: 188K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

    Insiders: Clustered insider buying became public on 26 Jul 2025

    DiaMedica Therapeutics had 3 insiders buy $16.8M of its shares on the open market within 30 days (3 filings).

    Independent buyers
    3
    Purchase filings (Form 4, code P)
    3
    Total bought
    $16.8M
    Window
    26 Jun 2025 to 26 Jul 2025

    Fires when at least 3 independent insiders (joint filers count once) buy on the open market in 30 days, in at least 2 filings, for $100K or more in total; amendments do not count.

    Short interest and volume: Short interest spike became public on 25 Jul 2025

    DiaMedica Therapeutics had 2.4M shares sold short in the 15 Jul 2025 report, 14× the same report last year.

    This period
    2.4M (the 15 Jul 2025 report)
    Normal report (median of 24 earlier)
    202K
    Typical spread (median absolute deviation)
    55K
    How far from its usual level
    +27.3
    Same report last year
    174K
    History used
    2,405 days
    2024-07-15: 174K2024-07-31: 144K2024-08-15: 142K2024-08-30: 139K2024-09-13: 138K2024-09-30: 152K2024-10-15: 183K2024-10-31: 176K2024-11-15: 172K2024-11-29: 151K2024-12-13: 195K2024-12-31: 223K2025-01-15: 209K2025-01-31: 192K2025-02-14: 232K2025-02-28: 254K2025-03-14: 264K2025-03-31: 366K2025-04-15: 371K2025-04-30: 620K2025-05-15: 857K2025-05-30: 1.1M2025-06-13: 1.2M2025-06-30: 2.1M2025-07-15: 2.4M
    the 15 Jul 2025 report24 earlier reportsnormal: 202K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

    Short interest and volume: Short interest spike became public on 12 Aug 2025

    DiaMedica Therapeutics had 3.3M shares sold short in the 31 Jul 2025 report, 23× the same report last year.

    This period
    3.3M (the 31 Jul 2025 report)
    Normal report (median of 24 earlier)
    216K
    Typical spread (median absolute deviation)
    68K
    How far from its usual level
    +30.3
    Same report last year
    144K
    History used
    2,421 days
    2024-07-31: 144K2024-08-15: 142K2024-08-30: 139K2024-09-13: 138K2024-09-30: 152K2024-10-15: 183K2024-10-31: 176K2024-11-15: 172K2024-11-29: 151K2024-12-13: 195K2024-12-31: 223K2025-01-15: 209K2025-01-31: 192K2025-02-14: 232K2025-02-28: 254K2025-03-14: 264K2025-03-31: 366K2025-04-15: 371K2025-04-30: 620K2025-05-15: 857K2025-05-30: 1.1M2025-06-13: 1.2M2025-06-30: 2.1M2025-07-15: 2.4M2025-07-31: 3.3M
    the 31 Jul 2025 report24 earlier reportsnormal: 216K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

    Short interest and volume: Short interest spike became public on 27 Aug 2025

    DiaMedica Therapeutics had 3.8M shares sold short in the 15 Aug 2025 report, 27× the same report last year.

    This period
    3.8M (the 15 Aug 2025 report)
    Normal report (median of 24 earlier)
    228K
    Typical spread (median absolute deviation)
    81K
    How far from its usual level
    +30.1
    Same report last year
    142K
    History used
    2,436 days
    2024-08-15: 142K2024-08-30: 139K2024-09-13: 138K2024-09-30: 152K2024-10-15: 183K2024-10-31: 176K2024-11-15: 172K2024-11-29: 151K2024-12-13: 195K2024-12-31: 223K2025-01-15: 209K2025-01-31: 192K2025-02-14: 232K2025-02-28: 254K2025-03-14: 264K2025-03-31: 366K2025-04-15: 371K2025-04-30: 620K2025-05-15: 857K2025-05-30: 1.1M2025-06-13: 1.2M2025-06-30: 2.1M2025-07-15: 2.4M2025-07-31: 3.3M2025-08-15: 3.8M
    the 15 Aug 2025 report24 earlier reportsnormal: 228K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

    Short interest and volume: Short interest spike became public on 11 Sep 2025

    DiaMedica Therapeutics had 4.0M shares sold short in the 29 Aug 2025 report, 29× the same report last year.

    This period
    4.0M (the 29 Aug 2025 report)
    Normal report (median of 24 earlier)
    243K
    Typical spread (median absolute deviation)
    98K
    How far from its usual level
    +26.2
    Same report last year
    139K
    History used
    2,450 days
    2024-08-30: 139K2024-09-13: 138K2024-09-30: 152K2024-10-15: 183K2024-10-31: 176K2024-11-15: 172K2024-11-29: 151K2024-12-13: 195K2024-12-31: 223K2025-01-15: 209K2025-01-31: 192K2025-02-14: 232K2025-02-28: 254K2025-03-14: 264K2025-03-31: 366K2025-04-15: 371K2025-04-30: 620K2025-05-15: 857K2025-05-30: 1.1M2025-06-13: 1.2M2025-06-30: 2.1M2025-07-15: 2.4M2025-07-31: 3.3M2025-08-15: 3.8M2025-08-29: 4.0M
    the 29 Aug 2025 report24 earlier reportsnormal: 243K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

    Short interest and volume: Short interest spike became public on 25 Sep 2025

    DiaMedica Therapeutics had 4.1M shares sold short in the 15 Sep 2025 report, 30× the same report last year.

    This period
    4.1M (the 15 Sep 2025 report)
    Normal report (median of 24 earlier)
    259K
    Typical spread (median absolute deviation)
    107K
    How far from its usual level
    +24.2
    Same report last year
    138K
    History used
    2,467 days
    2024-09-13: 138K2024-09-30: 152K2024-10-15: 183K2024-10-31: 176K2024-11-15: 172K2024-11-29: 151K2024-12-13: 195K2024-12-31: 223K2025-01-15: 209K2025-01-31: 192K2025-02-14: 232K2025-02-28: 254K2025-03-14: 264K2025-03-31: 366K2025-04-15: 371K2025-04-30: 620K2025-05-15: 857K2025-05-30: 1.1M2025-06-13: 1.2M2025-06-30: 2.1M2025-07-15: 2.4M2025-07-31: 3.3M2025-08-15: 3.8M2025-08-29: 4.0M2025-09-15: 4.1M
    the 15 Sep 2025 report24 earlier reportsnormal: 259K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

    Short interest and volume: Short interest spike became public on 10 Oct 2025

    DiaMedica Therapeutics had 4.2M shares sold short in the 30 Sep 2025 report, 28× the same report last year.

    This period
    4.2M (the 30 Sep 2025 report)
    Normal report (median of 24 earlier)
    315K
    Typical spread (median absolute deviation)
    153K
    How far from its usual level
    +17.3
    Same report last year
    152K
    History used
    2,482 days
    2024-09-30: 152K2024-10-15: 183K2024-10-31: 176K2024-11-15: 172K2024-11-29: 151K2024-12-13: 195K2024-12-31: 223K2025-01-15: 209K2025-01-31: 192K2025-02-14: 232K2025-02-28: 254K2025-03-14: 264K2025-03-31: 366K2025-04-15: 371K2025-04-30: 620K2025-05-15: 857K2025-05-30: 1.1M2025-06-13: 1.2M2025-06-30: 2.1M2025-07-15: 2.4M2025-07-31: 3.3M2025-08-15: 3.8M2025-08-29: 4.0M2025-09-15: 4.1M2025-09-30: 4.2M
    the 30 Sep 2025 report24 earlier reportsnormal: 315K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

    Short interest and volume: Short interest spike became public on 25 Oct 2025

    DiaMedica Therapeutics had 4.1M shares sold short in the 15 Oct 2025 report, 22× the same report last year.

    This period
    4.1M (the 15 Oct 2025 report)
    Normal report (median of 24 earlier)
    369K
    Typical spread (median absolute deviation)
    207K
    How far from its usual level
    +12.2
    Same report last year
    183K
    History used
    2,497 days
    2024-10-15: 183K2024-10-31: 176K2024-11-15: 172K2024-11-29: 151K2024-12-13: 195K2024-12-31: 223K2025-01-15: 209K2025-01-31: 192K2025-02-14: 232K2025-02-28: 254K2025-03-14: 264K2025-03-31: 366K2025-04-15: 371K2025-04-30: 620K2025-05-15: 857K2025-05-30: 1.1M2025-06-13: 1.2M2025-06-30: 2.1M2025-07-15: 2.4M2025-07-31: 3.3M2025-08-15: 3.8M2025-08-29: 4.0M2025-09-15: 4.1M2025-09-30: 4.2M2025-10-15: 4.1M
    the 15 Oct 2025 report24 earlier reportsnormal: 369K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

    Short interest and volume: Short interest spike became public on 13 Nov 2025

    DiaMedica Therapeutics had 4.1M shares sold short in the 31 Oct 2025 report, 23× the same report last year.

    This period
    4.1M (the 31 Oct 2025 report)
    Normal report (median of 24 earlier)
    496K
    Typical spread (median absolute deviation)
    334K
    How far from its usual level
    +7.3
    Same report last year
    176K
    History used
    2,513 days
    2024-10-31: 176K2024-11-15: 172K2024-11-29: 151K2024-12-13: 195K2024-12-31: 223K2025-01-15: 209K2025-01-31: 192K2025-02-14: 232K2025-02-28: 254K2025-03-14: 264K2025-03-31: 366K2025-04-15: 371K2025-04-30: 620K2025-05-15: 857K2025-05-30: 1.1M2025-06-13: 1.2M2025-06-30: 2.1M2025-07-15: 2.4M2025-07-31: 3.3M2025-08-15: 3.8M2025-08-29: 4.0M2025-09-15: 4.1M2025-09-30: 4.2M2025-10-15: 4.1M2025-10-31: 4.1M
    the 31 Oct 2025 report24 earlier reportsnormal: 496K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

    Short interest and volume: Short interest spike became public on 26 Nov 2025

    DiaMedica Therapeutics had 5.0M shares sold short in the 14 Nov 2025 report, 29× the same report last year.

    This period
    5.0M (the 14 Nov 2025 report)
    Normal report (median of 24 earlier)
    738K
    Typical spread (median absolute deviation)
    545K
    How far from its usual level
    +5.3
    Same report last year
    172K
    History used
    2,527 days
    2024-11-15: 172K2024-11-29: 151K2024-12-13: 195K2024-12-31: 223K2025-01-15: 209K2025-01-31: 192K2025-02-14: 232K2025-02-28: 254K2025-03-14: 264K2025-03-31: 366K2025-04-15: 371K2025-04-30: 620K2025-05-15: 857K2025-05-30: 1.1M2025-06-13: 1.2M2025-06-30: 2.1M2025-07-15: 2.4M2025-07-31: 3.3M2025-08-15: 3.8M2025-08-29: 4.0M2025-09-15: 4.1M2025-09-30: 4.2M2025-10-15: 4.1M2025-10-31: 4.1M2025-11-14: 5.0M
    the 14 Nov 2025 report24 earlier reportsnormal: 738K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

    Short interest and volume: Short interest spike became public on 10 Dec 2025

    DiaMedica Therapeutics had 5.3M shares sold short in the 28 Nov 2025 report, 35× the same report last year.

    This period
    5.3M (the 28 Nov 2025 report)
    Normal report (median of 24 earlier)
    978K
    Typical spread (median absolute deviation)
    785K
    How far from its usual level
    +3.7
    Same report last year
    151K
    History used
    2,541 days
    2024-11-29: 151K2024-12-13: 195K2024-12-31: 223K2025-01-15: 209K2025-01-31: 192K2025-02-14: 232K2025-02-28: 254K2025-03-14: 264K2025-03-31: 366K2025-04-15: 371K2025-04-30: 620K2025-05-15: 857K2025-05-30: 1.1M2025-06-13: 1.2M2025-06-30: 2.1M2025-07-15: 2.4M2025-07-31: 3.3M2025-08-15: 3.8M2025-08-29: 4.0M2025-09-15: 4.1M2025-09-30: 4.2M2025-10-15: 4.1M2025-10-31: 4.1M2025-11-14: 5.0M2025-11-28: 5.3M
    the 28 Nov 2025 report24 earlier reportsnormal: 978K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

    Several things at once means two or more unrelated kinds of records changed sharply within 30 days. Records that come from the same documents (for example filings and the financials taken from them) count as one kind.

  15. 26 Jul 2025Insiders change

    had 3 insiders buy $16.8M of its shares on the open market within 30 days (3 filings).

    Who bought: Jacinto Richard Ii.

    See the evidence (3 source records)
    Independent buyers
    3
    Purchase filings (Form 4, code P)
    3
    Total bought
    $16.8M
    Window
    26 Jun 2025 to 26 Jul 2025

    Fires when at least 3 independent insiders (joint filers count once) buy on the open market in 30 days, in at least 2 filings, for $100K or more in total; amendments do not count.

  16. 26 Jul 2025Insiders record

    JACINTO RICHARD II (ten percent owner) bought 400,000 shares of DMAC ($1.4M) (dated 25 Jul 2025)

  17. 26 Jul 2025Insiders record

    STAHLBERG JAN (ten percent owner) and 1 other(s) bought 1,542,857 shares of DMAC ($5.4M) (dated 25 Jul 2025)

  18. 26 Jul 2025Insiders record

    Von Koch Thomas (ten percent owner) and 2 other(s) bought 2,857,142 shares of DMAC ($10.0M) (dated 25 Jul 2025)

  19. 25 Jul 2025Short interest and volume change

    had 2.4M shares sold short in the 15 Jul 2025 report, 14× the same report last year.

    Same report last year: 174K; its normal report is 202K.

    See the evidence
    This period
    2.4M (the 15 Jul 2025 report)
    Normal report (median of 24 earlier)
    202K
    Typical spread (median absolute deviation)
    55K
    How far from its usual level
    +27.3
    Same report last year
    174K
    History used
    2,405 days
    2024-07-15: 174K2024-07-31: 144K2024-08-15: 142K2024-08-30: 139K2024-09-13: 138K2024-09-30: 152K2024-10-15: 183K2024-10-31: 176K2024-11-15: 172K2024-11-29: 151K2024-12-13: 195K2024-12-31: 223K2025-01-15: 209K2025-01-31: 192K2025-02-14: 232K2025-02-28: 254K2025-03-14: 264K2025-03-31: 366K2025-04-15: 371K2025-04-30: 620K2025-05-15: 857K2025-05-30: 1.1M2025-06-13: 1.2M2025-06-30: 2.1M2025-07-15: 2.4M
    the 15 Jul 2025 report24 earlier reportsnormal: 202K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  20. 24 Jul 2025Filings record

    Private placement of securities (Form D)

  21. 26 Jun 2025Short interest and volume change

    had 1.2M shares sold short in the 13 Jun 2025 report, 9.6× the same report last year.

    Same report last year: 128K; its normal report is 188K.

    See the evidence
    This period
    1.2M (the 13 Jun 2025 report)
    Normal report (median of 24 earlier)
    188K
    Typical spread (median absolute deviation)
    44K
    How far from its usual level
    +16.0
    Same report last year
    128K
    History used
    2,373 days
    2024-06-14: 128K2024-06-28: 157K2024-07-15: 174K2024-07-31: 144K2024-08-15: 142K2024-08-30: 139K2024-09-13: 138K2024-09-30: 152K2024-10-15: 183K2024-10-31: 176K2024-11-15: 172K2024-11-29: 151K2024-12-13: 195K2024-12-31: 223K2025-01-15: 209K2025-01-31: 192K2025-02-14: 232K2025-02-28: 254K2025-03-14: 264K2025-03-31: 366K2025-04-15: 371K2025-04-30: 620K2025-05-15: 857K2025-05-30: 1.1M2025-06-13: 1.2M
    the 13 Jun 2025 report24 earlier reportsnormal: 188K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  22. 11 Jun 2025Short interest and volume change

    had 1.1M shares sold short in the 30 May 2025 report, 8.4× the same report last year.

    Same report last year: 131K; its normal report is 179K.

    See the evidence
    This period
    1.1M (the 30 May 2025 report)
    Normal report (median of 24 earlier)
    179K
    Typical spread (median absolute deviation)
    39K
    How far from its usual level
    +16.0
    Same report last year
    131K
    History used
    2,359 days
    2024-05-31: 131K2024-06-14: 128K2024-06-28: 157K2024-07-15: 174K2024-07-31: 144K2024-08-15: 142K2024-08-30: 139K2024-09-13: 138K2024-09-30: 152K2024-10-15: 183K2024-10-31: 176K2024-11-15: 172K2024-11-29: 151K2024-12-13: 195K2024-12-31: 223K2025-01-15: 209K2025-01-31: 192K2025-02-14: 232K2025-02-28: 254K2025-03-14: 264K2025-03-31: 366K2025-04-15: 371K2025-04-30: 620K2025-05-15: 857K2025-05-30: 1.1M
    the 30 May 2025 report24 earlier reportsnormal: 179K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  23. 28 May 2025Short interest and volume change

    had 857K shares sold short in the 15 May 2025 report, 6.7× the same report last year.

    Same report last year: 129K; its normal report is 175K.

    See the evidence
    This period
    857K (the 15 May 2025 report)
    Normal report (median of 24 earlier)
    175K
    Typical spread (median absolute deviation)
    35K
    How far from its usual level
    +13.1
    Same report last year
    129K
    History used
    2,344 days
    2024-05-15: 129K2024-05-31: 131K2024-06-14: 128K2024-06-28: 157K2024-07-15: 174K2024-07-31: 144K2024-08-15: 142K2024-08-30: 139K2024-09-13: 138K2024-09-30: 152K2024-10-15: 183K2024-10-31: 176K2024-11-15: 172K2024-11-29: 151K2024-12-13: 195K2024-12-31: 223K2025-01-15: 209K2025-01-31: 192K2025-02-14: 232K2025-02-28: 254K2025-03-14: 264K2025-03-31: 366K2025-04-15: 371K2025-04-30: 620K2025-05-15: 857K
    the 15 May 2025 report24 earlier reportsnormal: 175K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  24. 10 May 2025Short interest and volume change

    had 620K shares sold short in the 30 Apr 2025 report, 3.4× the same report last year.

    Same report last year: 182K; its normal report is 175K.

    See the evidence
    This period
    620K (the 30 Apr 2025 report)
    Normal report (median of 24 earlier)
    175K
    Typical spread (median absolute deviation)
    34K
    How far from its usual level
    +8.9
    Same report last year
    182K
    History used
    2,329 days
    2024-04-30: 182K2024-05-15: 129K2024-05-31: 131K2024-06-14: 128K2024-06-28: 157K2024-07-15: 174K2024-07-31: 144K2024-08-15: 142K2024-08-30: 139K2024-09-13: 138K2024-09-30: 152K2024-10-15: 183K2024-10-31: 176K2024-11-15: 172K2024-11-29: 151K2024-12-13: 195K2024-12-31: 223K2025-01-15: 209K2025-01-31: 192K2025-02-14: 232K2025-02-28: 254K2025-03-14: 264K2025-03-31: 366K2025-04-15: 371K2025-04-30: 620K
    the 30 Apr 2025 report24 earlier reportsnormal: 175K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  25. 6 Mar 2025Filings record

    Director or officer change

  26. 24 Feb 2025Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  27. 24 Feb 2025Filings record

    Director or officer change

  28. 2 Jul 2024Filings record

    Private placement of securities (Form D)

  29. 2 Jul 2024Insiders record

    STAHLBERG JAN (ten percent owner) and 1 other(s) bought 1,200,000 shares of DMAC ($3.0M) (dated 1 Jul 2024)

  30. 2 Jul 2024Insiders record

    TomEnterprise Private AB (ten percent owner) and 2 other(s) bought 1,200,000 shares of DMAC ($3.0M) (dated 1 Jul 2024)

  31. 23 May 2024Filings record

    Director or officer change

  32. 10 Apr 2024Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  33. 10 Apr 2024Filings record

    Director or officer change

  34. 17 Nov 2023Insiders record

    Wambeke David J. (Chief Business Officer) bought 20,000 shares of DMAC ($49,200) (dated 16 Nov 2023)

  35. 5 Sep 2023Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  36. 5 Sep 2023Filings record

    Director or officer change

  37. 26 Jul 2023Short interest and volume change

    had 796K shares sold short in the 14 Jul 2023 report, 16× the same report last year.

    Same report last year: 48K; its normal report is 56K.

    See the evidence
    This period
    796K (the 14 Jul 2023 report)
    Normal report (median of 24 earlier)
    56K
    Typical spread (median absolute deviation)
    21K
    How far from its usual level
    +14.8
    Same report last year
    48K
    History used
    1,673 days
    2022-07-15: 48K2022-07-29: 54K2022-08-15: 53K2022-08-31: 30K2022-09-15: 77K2022-09-30: 29K2022-10-14: 101K2022-10-31: 53K2022-11-15: 35K2022-11-30: 43K2022-12-15: 40K2022-12-30: 85K2023-01-13: 80K2023-01-31: 34K2023-02-15: 41K2023-02-28: 41K2023-03-15: 59K2023-03-31: 91K2023-04-14: 97K2023-04-28: 92K2023-05-15: 84K2023-05-31: 66K2023-06-15: 71K2023-06-30: 714K2023-07-14: 796K
    the 14 Jul 2023 report24 earlier reportsnormal: 56K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  38. 18 Jul 2023several at once

    had 6 insiders buy $693K of its shares on the open market within 30 days (6 filings), while it had 796K shares sold short in the 14 Jul 2023 report, 16× the same report last year. Two unrelated kinds of activity within 35 days.

    See the evidence (3 changes)

    Insiders: Clustered insider buying became public on 27 Jun 2023

    DiaMedica Therapeutics had 6 insiders buy $693K of its shares on the open market within 30 days (6 filings).

    Independent buyers
    6
    Purchase filings (Form 4, code P)
    6
    Total bought
    $693K
    Window
    28 May 2023 to 27 Jun 2023

    Fires when at least 3 independent insiders (joint filers count once) buy on the open market in 30 days, in at least 2 filings, for $100K or more in total; amendments do not count.

    Short interest and volume: Short interest spike became public on 13 Jul 2023

    DiaMedica Therapeutics had 714K shares sold short in the 30 Jun 2023 report, 14× the same report last year.

    This period
    714K (the 30 Jun 2023 report)
    Normal report (median of 24 earlier)
    54K
    Typical spread (median absolute deviation)
    18K
    How far from its usual level
    +13.2
    Same report last year
    53K
    History used
    1,659 days
    2022-06-30: 53K2022-07-15: 48K2022-07-29: 54K2022-08-15: 53K2022-08-31: 30K2022-09-15: 77K2022-09-30: 29K2022-10-14: 101K2022-10-31: 53K2022-11-15: 35K2022-11-30: 43K2022-12-15: 40K2022-12-30: 85K2023-01-13: 80K2023-01-31: 34K2023-02-15: 41K2023-02-28: 41K2023-03-15: 59K2023-03-31: 91K2023-04-14: 97K2023-04-28: 92K2023-05-15: 84K2023-05-31: 66K2023-06-15: 71K2023-06-30: 714K
    the 30 Jun 2023 report24 earlier reportsnormal: 54K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

    Short interest and volume: Short interest spike became public on 26 Jul 2023

    DiaMedica Therapeutics had 796K shares sold short in the 14 Jul 2023 report, 16× the same report last year.

    This period
    796K (the 14 Jul 2023 report)
    Normal report (median of 24 earlier)
    56K
    Typical spread (median absolute deviation)
    21K
    How far from its usual level
    +14.8
    Same report last year
    48K
    History used
    1,673 days
    2022-07-15: 48K2022-07-29: 54K2022-08-15: 53K2022-08-31: 30K2022-09-15: 77K2022-09-30: 29K2022-10-14: 101K2022-10-31: 53K2022-11-15: 35K2022-11-30: 43K2022-12-15: 40K2022-12-30: 85K2023-01-13: 80K2023-01-31: 34K2023-02-15: 41K2023-02-28: 41K2023-03-15: 59K2023-03-31: 91K2023-04-14: 97K2023-04-28: 92K2023-05-15: 84K2023-05-31: 66K2023-06-15: 71K2023-06-30: 714K2023-07-14: 796K
    the 14 Jul 2023 report24 earlier reportsnormal: 56K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

    Several things at once means two or more unrelated kinds of records changed sharply within 30 days. Records that come from the same documents (for example filings and the financials taken from them) count as one kind.

  39. 13 Jul 2023Short interest and volume change

    had 714K shares sold short in the 30 Jun 2023 report, 14× the same report last year.

    Same report last year: 53K; its normal report is 54K.

    See the evidence
    This period
    714K (the 30 Jun 2023 report)
    Normal report (median of 24 earlier)
    54K
    Typical spread (median absolute deviation)
    18K
    How far from its usual level
    +13.2
    Same report last year
    53K
    History used
    1,659 days
    2022-06-30: 53K2022-07-15: 48K2022-07-29: 54K2022-08-15: 53K2022-08-31: 30K2022-09-15: 77K2022-09-30: 29K2022-10-14: 101K2022-10-31: 53K2022-11-15: 35K2022-11-30: 43K2022-12-15: 40K2022-12-30: 85K2023-01-13: 80K2023-01-31: 34K2023-02-15: 41K2023-02-28: 41K2023-03-15: 59K2023-03-31: 91K2023-04-14: 97K2023-04-28: 92K2023-05-15: 84K2023-05-31: 66K2023-06-15: 71K2023-06-30: 714K
    the 30 Jun 2023 report24 earlier reportsnormal: 54K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  40. 28 Jun 2023Insiders record

    TomEqt Private AB (ten percent owner) and 2 other(s) bought 1,470,588 shares of DMAC ($5.0M) (dated 27 Jun 2023)

Showing the newest 40 of 106 entries; narrow the window or the kind of data to see older ones.

Not listed: 103 routine records (quarterly and annual reports, results releases, other 8-K items, material agreements and individual insider sales), counted over all history.

Identifiers and sources

How records are matched to this company, and what each source holds for it

Cik
0001401040
Ticker
DMAC
Domain
diamedica.com
Hq location
MN|MINNEAPOLIS|55305 (1 unverified)
Name
DiaMedica Inc., DiaMedica Therapeutics Inc.
  • SEC Form 13F institutional holdings288 data points31 Dec 2018 to 30 Sep 2026
  • SEC EDGAR filings (8-K items, S-1, Form D, 10-K/10-Q)128 records17 Apr 2018 to 12 Nov 2026
  • SEC XBRL company facts (revenue, capex, R&D, backlog...)459 data points31 Dec 2016 to 9 Nov 2026
  • SEC Form 4 insider transactions49 records, 108 data points11 Dec 2018 to 8 Dec 2025
  • FINRA short interest (twice monthly)567 data points14 Dec 2018 to 30 Oct 2026
  • FINRA daily short sale volume (off-exchange)3992 data points7 Dec 2018 to 20 Nov 2026